The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease-Reference-Cited by-同舟云学术

The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease

Published:2008-08 Issue:12 Volume:41 Page:981-985
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Catalano Mariella,Cortelazzo Adriano,Santi Roberto,Contino Laura,Demicheli Marta,Yilmaz Yusuf,Zorzetto Michele,Campo Ilaria,Lanati Niccolò,Emanuele Enzo

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference18 articles.

1. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease;Shammas;Vasc Health Risk Manag,2007

2. Proinflammatory circulating molecules in peripheral arterial disease;Signorelli;Int J Mol Med,2007

3. Peroxisome proliferator-activated receptor-gamma in vascular biology;Li;Cardiovasc Hematol Disord Drug Targets,2007

4. Peroxisome proliferator-activated receptors;Ziouzenkova;Curr Atheroscler Rep,2002

5. Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptor gamma and osteoprotegerin levels as an indicator and diagnostic predictor of endothelial dysfunction;Turkish Journal of Biochemistry;2023-11-27

2. Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study;Frontiers in Endocrinology;2023-08-11

3. Nuclear receptors as potential therapeutic targets in peripheral arterial disease and related myopathy;The FEBS Journal;2022-08-18

4. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors;International Journal of Molecular Sciences;2021-06-27

5. Role of Ligands of Receptor for Advanced Glycation End Products (RAGE) in Peripheral Artery Disease;Rejuvenation Research;2018-10